Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Oral Oncology|November 7, 2009
Development of a gene transfer-based treatment for radiation-induced salivary hypofunctionBruce J Baum, Changyu Zheng, Ilias Alevizos, et al.Arthritis Research & Therapy|December 13, 2019
LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltrationJunjun Luan, Jingqi Fu, Chengjie Chen, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 12, 2009
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosusMatthew H Liang, Julia F Simard, Karen Costenbader, et al.Handbook of Experimental Pharmacology|December 20, 2008
Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunctionBruce J Baum, Changyu Zheng, Ana P Cotrim, et al.Rheumatology (Oxford, England)|February 24, 2007
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritisG G Illei, C H Yarboro, T Kuroiwa, et al.Oxidative Medicine and Cellular Longevity|October 21, 2022
circMTND5 Participates in Renal Mitochondrial Injury and Fibrosis by Sponging MIR6812 in Lupus NephritisJunjun Luan, Congcong Jiao, Cong Ma, et al.Annals of the Rheumatic Diseases|April 12, 2006
The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosusG Oroszi, L Lapteva, E Davis, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001
IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritisI B McInnes, G G Illei, C L Danning, et al.Oral Diseases|November 26, 2016
Immune reactivity after adenoviral-mediated aquaporin-1 cDNA transfer to human parotid glandsI Alevizos, C Zheng, A P Cotrim, et al.Annals of Internal Medicine|August 21, 2001
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritisG G Illei, H A Austin, M Crane, et al.Pageof 11